ID: ALA276298

Max Phase: Preclinical

Molecular Formula: C31H50O5

Molecular Weight: 502.74

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC(=O)[C@]12CC[C@@H](C)[C@H](C)C1C1=CCC3[C@@]4(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)C4CC[C@@]3(C)[C@]1(C)CC2

Standard InChI:  InChI=1S/C31H50O5/c1-18-10-13-31(26(35)36-7)15-14-29(5)20(24(31)19(18)2)8-9-23-27(3)16-21(33)25(34)28(4,17-32)22(27)11-12-30(23,29)6/h8,18-19,21-25,32-34H,9-17H2,1-7H3/t18-,19+,21-,22?,23?,24?,25+,27+,28+,29-,30-,31+/m1/s1

Standard InChI Key:  PTVQHIGQUFDPIQ-OJFQKVMMSA-N

Associated Targets(non-human)

B103 cell line 42 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 502.74Molecular Weight (Monoisotopic): 502.3658AlogP: 5.12#Rotatable Bonds: 2
Polar Surface Area: 86.99Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.55CX Basic pKa: CX LogP: 4.37CX LogD: 4.37
Aromatic Rings: 0Heavy Atoms: 36QED Weighted: 0.36Np Likeness Score: 3.19

References

1. Jew SS, Yoo CH, Lim DY, Kim H, Mook-Jung I, Jung MW, Choi H, Jung YH, Kim H, Park HG..  (2000)  Structure-activity relationship study of asiatic acid derivatives against beta amyloid (A beta)-induced neurotoxicity.,  10  (2): [PMID:10673093] [10.1016/s0960-894x(99)00658-7]

Source